Lead Exposure and Prevention Advisory Committee (LEPAC); Notice of Recharter

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published

February 24, 2022

Issuing agencies

Health and Human Services DepartmentCenters for Disease Control and Prevention

Abstract

This gives notice under the Federal Advisory Committee Act of October 6, 1972, that the Lead Exposure and Prevention Advisory Committee (LEPAC), Centers for Disease Control and Prevention, Department of Health and Human Services, has been renewed for a 2-year period through January 17, 2024.

Full Text

<html>
<head>
<title>Federal Register, Volume 87 Issue 37 (Thursday, February 24, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 37 (Thursday, February 24, 2022)]
[Notices]
[Page 10366]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-03865]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Lead Exposure and Prevention Advisory Committee (LEPAC); Notice 
of Recharter

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of recharter.

-----------------------------------------------------------------------

SUMMARY: This gives notice under the Federal Advisory Committee Act of 
October 6, 1972, that the Lead Exposure and Prevention Advisory 
Committee (LEPAC), Centers for Disease Control and Prevention, 
Department of Health and Human Services, has been renewed for a 2-year 
period through January 17, 2024.

FOR FURTHER INFORMATION CONTACT: Paul Allwood, Ph.D., MPH, RS, 
Designated Federal Officer, Branch Chief, National Center for 
Environmental Health, CDC, 4770 Buford Highway NE, Atlanta, Georgia 
30341, telephone (770) 488-6774; <a href="/cdn-cgi/l/email-protection#2e7e6f42425941414a6e4d4a4d00494158"><span class="__cf_email__" data-cfemail="0e5e4f62627961616a4e6d6a6d20696178">[email&#160;protected]</span></a>.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-03865 Filed 2-23-22; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>

View on FederalRegister.gov →Plain-text source

Indexed from Federal Register on February 24, 2022.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.